Highlights: Cangrelor significantly reduces ischaemic events compared with clopidogrel; transcatheter aortic valve still works after three years in high-risk patients; novel drug could reduce heart damage during angioplasty. Profile: Morton Kern
Highlights: Cangrelor significantly reduces ischaemic events compared with clopidogrel; transcatheter aortic valve still works after three years in high-risk patients; novel drug could reduce heart damage during angioplasty. Profile: Morton Kern